What are the best treatments for Huntingtons Disease?

Currently, there is no cure for Huntington's disease, so treatment focuses on managing symptoms to improve quality of life through a combination of pharmacological interventions and supportive therapies. Clinical management is highly personalized, typically involving a multidisciplinary team to address the motor, cognitive, and psychiatric challenges associated with Huntington's disease.

What are the primary medical treatments for Huntington's disease?

Treatment for Huntington's disease is symptomatic, meaning medications are used to target specific manifestations of the condition. For chorea (involuntary, jerky movements), the FDA has approved vesicular monoamine transporter 2 (VMAT2) inhibitors, such as tetrabenazine (Xenazine) and deutetrabenazine (Austedo). These medications work by depleting dopamine in the brain to reduce movement severity. For psychiatric symptoms, such as irritability, depression, or obsessive-compulsive behaviors, clinicians often prescribe selective serotonin reuptake inhibitors (SSRIs) or antipsychotic medications. Because every patient experiences Huntington's disease differently, these medications must be carefully titrated by a specialist to balance symptom control with potential side effects like fatigue or sedation.

What non-pharmacological therapies support patients?

Non-pharmacological interventions are essential to maintaining functional independence and emotional well-being for those living with Huntington's disease. Physical therapy is vital for improving balance, gait, and strength, which helps reduce the risk of falls. Occupational therapy focuses on adapting the home environment and daily activities to accommodate changes in motor control. Additionally, speech therapy is frequently recommended to address dysarthria (speech difficulty) and dysphagia (swallowing challenges), which are common as the disease progresses.

Which specialists should be on the care team?

Managing Huntington's disease requires a coordinated approach from a multidisciplinary team. A typical care team often includes:

• Neurologists: Specialists with expertise in movement disorders to manage motor symptoms.


• Psychiatrists/Psychologists: To address the significant mood and behavioral changes often associated with Huntington's disease.


• Genetic Counselors: To provide guidance for families regarding the 50% inheritance risk for offspring.


• Physical and Occupational Therapists: To maintain mobility and functional autonomy.


• Social Workers: To assist with long-term care planning, insurance, and disability resources.

Are there emerging treatments or clinical trials?

The field of Huntington's disease research is rapidly evolving, with a major focus on disease-modifying therapies. Current clinical trials are investigating gene-silencing technologies, such as antisense oligonucleotides (ASOs), which aim to reduce the production of the toxic huntingtin protein. While these therapies are still under investigation and not yet standard practice, they represent a significant shift toward addressing the underlying genetic cause of Huntington's disease rather than just the symptoms.

How does treatment effectiveness vary?

Treatment effectiveness in Huntington's disease is highly variable due to the individual nature of the genetic mutation (specifically the CAG repeat length) and the patient's overall health status. Because Huntington's disease impacts each person differently—with some experiencing earlier onset of motor symptoms and others dealing primarily with cognitive or psychiatric decline—there is no "one-size-fits-all" protocol. Ongoing communication with your medical team is crucial to adjust treatments as the disease progresses.

Next steps

• Consult with a neurologist specializing in movement disorders to develop a personalized care plan.


• Connect with the 39 community members on DiseaseMaps.org to share experiences and learn from others living with Huntington's disease.


• Inquire about current clinical trials through the Huntington’s Disease Society of America (HDSA) or ClinicalTrials.gov.


• Schedule a session with a genetic counselor to discuss family planning and testing options.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare provider for personalized treatment recommendations.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Huntington's disease overview.


• Huntington’s Disease Society of America (HDSA): Comprehensive care and clinical guidelines.


• Orphanet: Rare disease database for Huntington's disease (ORPHA:399).


• OMIM (Online Mendelian Inheritance in Man): Clinical synopsis for HTT gene and Huntington's disease.